Use of viability PCR for detection of live Chlamydia trachomatis in clinical specimens
نویسندگان
چکیده
Background The current testing approach to diagnose Chlamydia trachomatis (CT) infection relies on nucleic acid amplification tests (NAATs). These are highly sensitive, but do not distinguish between active and residual bacterial which may remain after resolution of infection, or via cross-contamination. Better methods assess the viability CT detected in clinical samples would be useful determining relevance detection a variety settings. goal this study was test PCR (vPCR) as method viable bacteria from non-viable CT. Methods vPCR propidium monoazide dye (PMAxx), intercalates into accessible DNA dead organisms prevents their assay for ompA gene. We used digital quantify absolute genome copy numbers samples. validated using laboratory stocks with known viability. Then, we tested total DNA, culture results 18 vaginal specimens 25 rectal specimens, all had positive by NAAT. Results In CT, defined ratios heat-killed live tracked closely expected results. were correlated, though genomes outnumbered 2.2–52.6-fold more copies. As expected, than Both correlated (Spearman correlation R = 0.8425 0.8056 vPCR). Ten NAAT negative PCR, vPCR, inconclusive culture. Of 6 that positive, positive. additionally 8 + negative, levels very low (mean 1,357 copies/ml) Conclusions is fast easy PCR. Inconsistent suggest amount varies considerably specimens. many fact represent replicating bacteria, likely result significant overuse unnecessary antibiotics.
منابع مشابه
Development of TaqMan Duplex Real-time PCR for Simultaneous Detection of Chlamydia Trachomatis and Mycoplasma Genitalium
Background and Objective: Sexually infections transmitted by bacteria are one of thetherapeutic and social problemsworldwide. The Real-time PCR assay is one of the most sensitive diagnostic and screening methods for these infections. The purpose of this study wassimultaneous detection of Chlamydia trachomatis and Mycoplasma genitaliumusing the TaqMan duplex real-time polymerase chain reaction. ...
متن کاملGenotyping of Chlamydia trachomatis from endocervical specimens in Shiraz, Iran
The objective of this study was to determine the prevalence and distribution of Chlamydia trachomatisgenotypes in Shiraz, Iran. Two hundred twelve cervical swab samples were collected from women attendingShahid Motahari Polyclinic in Shiraz, Iran. The endocervical specimens were screened for C. trachomatis byplasmid PCR. Genotyping was performed in C. trachomatis-positive samples by nested PCR ...
متن کاملdetection of chlamydia trachomatis from urine specimens by pcr in women with cervicitis
chlamydia trachomatis is the most common agent of urogenital infections in both men and women. diagnosis of chlamydial infections is based on isolation of bacteria in tissue culture media that requires at least 48 to 72h. polymerase chain reaction (pcr) is a sensitive and specific method for detection of small quantity of bacterial dna in clinical samples. the first goal of this study was to pe...
متن کاملCOMPARISON OF PCR BASED ASSAY AND CELL CULTURE IN DETECTION OF UROGENITA L CHLAMYDIA TRACHOMATIS INFECTION AND DETERMINATION OF THE INHIBITORY RATE O F SPECIMENS UNDER STUDY
An amplification polymerase chain reaction (PCR) test for the direct detection of Chlamydia trachomatis in urethral and endocervical swab specimens from symptomatic and asymptomatic women and men were compared to standard culture technique. During 6 months, 300 endocervical swab specimens from 205 asymptomatic women (64.4%) and 95 symptomatic women (31.6%), and 187 urethral swab specime...
متن کاملDetection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay.
To determine that susceptibility of AMPLICOR Chlamydia trachomatis PCR to inhibitory factors possibly present in cervical specimens, we obtained cervical specimens from 200 gynecology patients attending our outpatient clinic. The prevalence of C. trachomatis infection was 4.1%, as determined by cell culture. All AMPLICOR specimens were tested in one procedure as described by the manufacturer, a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in reproductive health
سال: 2023
ISSN: ['2673-3153']
DOI: https://doi.org/10.3389/frph.2023.1199740